World

Musk's SpaceX to send five uncrewed Starships to Mars

Sep 24, 2024

New York [US], September 23: SpaceX plans to launch about five uncrewed Starship missions to Mars in two years, CEO Elon Musk has said in a post on social media platform X.
Earlier this month, Musk had said that the first Starships to Mars would launch in two years "when the next Earth-Mars transfer window opens".
The CEO on Sunday said that the first crewed mission timeline will depend upon the success of the uncrewed flights. If the uncrewed missions land safely, crewed missions will be launched in four years. However, in case of challenges, crewed missions will be postponed by another two years, Musk said.
Musk, known for providing changing timelines on Starship's readiness, said earlier this year that the first uncrewed starship to land on Mars would be within five years, with the first people landing on Mars within seven years.
In June, a Starship rocket survived a fiery, hypersonic return from space and achieved a breakthrough landing demonstration in the Indian Ocean, completing a full test mission around the globe on the rocket's fourth try.
Musk is counting on Starship to fulfil his goal of producing a large, multipurpose next-generation spacecraft capable of sending people and cargo to the moon later this decade, and ultimately flying to Mars.
NASA earlier this year delayed Artemis 3 mission and its first crewed moon landing in half a century using SpaceX's Starship, to September 2026. It was previously planned for late 2025, NASA said.
Japanese billionaire Yusaku Maezawa in June canceled a private mission around the moon he had paid for, which was to have used SpaceX's Starship, citing schedule uncertainties in the rocket's development.
Source: Fijian Broadcasting Corporation

More news

Niner Pharmaceuticals Expands into High-Purity Peptide Segment for Metabolic Health; Announces R&D for AI-Driven Ambientera Solution

Hyderabad (Telangana) [India], January 19: Niner Pharmaceuticals LLC has announced a major strategic expansion into the global high-purity peptide segment, shifting its focus beyond regulated supply chains to emphasize molecular innovation. The company aims to position these high-purity molecules as foundational tools for metabolic health, longevity, and recovery. In conjunction with this pharmaceutical expansion, the company has also disclosed that it is currently in the research and development phase for Ambientera, a new AI-driven home solution and residential operating system expected to launch next year.

Jan 19, 2026